ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,640.50
      0.16%
      US Tech 100
      19,889.20
      0.22%
      Dow Jones
      40,701.39
      1.22%
      Brent Oil
      83.175
      -1.38%
      Bitcoin
      63,136.26
      -2.64%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. USOTC
      6. RegeneRX Biopharmaceuticals Inc (CE) (RGRX)

      7. RegeneRX Biopharmaceuticals Inc (CE) (RGRX) News

      RGRX

      RegeneRX Biopharmaceutic... (CE) (RGRX)

      RegeneRX Biopharmaceuticals Inc (CE)
      		Date:
      Sort by:
       Showing the most relevant articles for your search:USOTC:RGRX
      DateTimeSourceHeadlineSymbolCompany
      07/06/20214:35PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      07/06/20214:34PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      07/01/20213:44PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      05/14/20213:08PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      03/19/202112:56PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      03/02/20214:10PMEdgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      02/08/20216:29PMEdgar (US Regulatory)Annual Statement of Changes in Beneficial Ownership (5)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      11/13/20204:06PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/20/20205:19PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/20/20205:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/20/20205:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/16/20204:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/16/20204:17PMEdgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      10/13/20207:01AMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      08/18/20206:06AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      08/14/20204:05PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:18PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:13PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:12PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      06/12/20206:10PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      05/15/20209:47AMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      03/30/20203:41PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      03/30/20203:40PMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      03/20/20204:46PMEdgar (US Regulatory)Annual Report (10-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      11/19/20196:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      11/19/20196:01AMEdgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      11/14/20194:06PMEdgar (US Regulatory)Quarterly Report (10-q)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
      09/30/20195:00PMEdgar (US Regulatory)Current Report Filing (8-k)USOTC:RGRXRegeneRX Biopharmaceuticals Inc (CE)
       Showing the most relevant articles for your search:USOTC:RGRX